[1]
L. Lezaic, S. Rep, K. Sirca, Ema Macek Lezaic, K. Zaletel, and M. Hocevar, “[18F]fluorocholine PET vs [99mTc]sestamibi scintigraphy in patients with primary hyperparathyroidism: outcomes and resource efficiency”, Radiol Oncol, vol. 58, no. 4, pp. 486–493, Nov. 2024.